Solutions
Insulin
VanishPoint Insulin Syringe
Immunization
VanishPoint Syringe
EasyPoint Needle
Blood Collection
EasyPoint Blood Collection Tube with Needle
VanishPoint Blood Collection Set
Allergy
VanishPoint Syringe
General Purpose
VanishPoint Syringe
EasyPoint Needle
Infusion
VanishPoint IV Catheter
Products
VanishPoint Syringe
VanishPoint Insulin Syringes
EasyPoint Needle
EasyPoint Blood Collection Tube with Needle
VanishPoint Blood Collection Set
VanishPoint IV Catheter
About
Careers
Investor Relations
Media
Blog
Latest Nurse Point Magazine Issue
Press Releases
Resources
Contact
Sales Directory
Questioning $1 Million Fee in a Needle Deal
rodneyhoganii
July 19, 2002
July 19, 2002
July 19, 2002
Press Releases
Questioning $1 Million Fee in a Needle Deal
Questioning $1 Million Fee in a Needle Deal
New York Times released an article today related to healthcare purchasing.
The article may be accessed by using the link below:
http://216.234.225.2/external.asp?b=577&id=69&from=pl
Previous Post
Next Post
YOU MAY ALSO LIKE
Our Latest Posts
Retractable Technologies Welcomes Congressional Leaders to Highlight Texas Innovation and U.S. Supply Chain Readiness
September 10, 2025
September 16, 2025
Retractable Technologies Welcomes Congressional Leaders to Highlight Texas Innovation and U.S. Supply Chain Readiness
Retractable Technologies, Inc. Results for the Periods Ended June 30, 2025
August 14, 2025
September 16, 2025
Retractable Technologies, Inc. Results for the Periods Ended June 30, 2025
Retractable Technologies, Inc. Declares Dividends to Series II and III Class B Preferred Stock Shareholders
June 30, 2025
September 16, 2025
Retractable Technologies, Inc. Declares Dividends to Series II and III Class B Preferred Stock Shareholders
Retractable Technologies, Inc. Results for the Period Ended March 31, 2025
May 15, 2025
May 15, 2025
Retractable Technologies, Inc. Results for the Period Ended March 31, 2025